Most Recent
Gram Engineering wins $2M in design patent case
Bluescope Steel has been ordered to pay over $2 million to fencing manufacturer Gram Engineering after the Federal Court ruled Bluescope infringed Gram’s registered design for a fencing panel sheet.
Rio Tinto subsidiary appeals after IP Australia rejects mining patent
Rio Tinto subsidiary Technological Resources Pty Ltd is appealing a decision by IP Australia to refuse a patent application for a method of separating mined material that was deemed a “purely logistical process”.
Judge halts Kraft-Bega arbitration in US while Aussie case proceeds
A judge has granted Bega's request to halt US arbitration proceedings between the Australian food maker and Kraft over peanut butter trade dress rights until a related case in Federal Court is resolved.
Gucci, Guess global settlement ends Australia action
Iconic fashion labels Gucci and Guess have agreed to a global settlement in their nine-year long courtroom battle over the famed "G" design trademark.
ObjectiVision panned for not monetising University of Sydney patent
A lawyer for the University of Sydney has attacked ObjectiVision for failing to produce any commercial benefits from the glaucoma detection method at the centre of a patent infringement dispute, despite holding exclusive rights to the technology for 11 years.
IP Australia rejects SNF challenge to BASF mining patent
The Australian Patent Office has shot down a challenge by SNF to a BASF application for a mining patent.
Apotex expert comes under fire at Lexapro patent infringement trial
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex' consultant took the brunt of it.
Geneva Labs can’t expand fake Bio-Oil case
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.
Writers’ Guild slams “mishmash” of evidence in royalties case
A barrister for the Australian Writers’ Guild has blasted documents produced by the non-profit Screenrights in a court battle over tens of millions of dollars in royalties payments, calling the evidence a "complete mishmash".
Lexapro maker squares off with generics in latest IP battle
The maker of the anti-depressant Lexapro faced off Monday against Apotex, Aspen Pharma and Sandoz at a court hearing over the rights to make generic versions of the top-selling product, with a barrister for Lundbeck slamming the three companies' defence that their drugs were different.